Lawmakers, Patients Ask CMS To Withdraw Medicaid Best Price Rule

By Ariel Cohen / October 27, 2020 at 5:12 PM
House members and patient lobbyists are concerned that CMS’ Medicaid value-based pricing proposed rule could curb drug innovation during the pandemic and make it more difficult for patients to access prescriptions. CMS proposed in June a rule that aims to avoid Medicaid “best price” pitfalls by making it easier for insurers to negotiate deals that allow drug prices to fluctuate based on how well drugs work, without forcing drug companies to sell drugs to Medicaid at very low prices. There’s...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.